RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech may trend higher after it formed a long white candle and breached above the MYR1.17 threshold. This upward momentum is likely to continue, given that it has formed a fourth consecutive white candle. A bullish bias may appear above the MYR1.17 level, with an exit set below the MYR1.08 mark. Towards the upside, the near-term resistance is at MYR1.26. This is followed by the MYR1.32 level.
Source: RHB Securities Research - 22 Mar 2019
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
Koon Yew Yin's Blog
3
TA Sector Research
4
Good Articles to Share
Le Pen makes new threat to withdraw support for French government
5
Good Articles to Share
US lawmakers say Hong Kong is becoming hub for financial crime — report
6
Good Articles to Share
7
Good Articles to Share
Global airfares set to rise yet again in 2025, Amex report says
8
M+ Online Research Articles
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
